Brief Case Studies in Professional and Patient Advocacy Relations: Best Practice Summary

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Learning by someone else’s mistakes and successes can save both time and money. Case studies assist companies in determining how to position their own market plans. Companies can use this information to recognize some of the pitfalls and successes in the realm of Professional and Advocacy Relations. This nine-page document covers eight case studies in the pharmaceutical industry.

Key topics include:
-- Overseas Advocacy: BMS' work with AIDS advocacy groups
-- Creating a Market: Pfizer’s work with advocacy groups during the launch of Viagra.
-- Crafting Cross-Therapeutic Activities: Janssen Pharmaceutica's ElderCare division and work surrounding products such as anti-psychotic Risperdal, pain reliever Duragesic and proton pump Aciphex.

The case studies draw on public domain documents and secondary research sources.

Industries Profiled:
Pharmaceutical; Health Care; Biotech; Medical Device

Companies Profiled:
Abbott Laboratories; AstraZeneca; Bristol-Myers Squibb; Eli Lilly; Merck; GlaxoSmithKline; Novartis; Pfizer; Roche

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Brief Case Studies in Professional and Patient Advocacy Relations

ID: 4265

Features:

Words: 2,562

Published: Pre-2019

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6CE5E57CBB129C74385256BA400537641
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/brief-case-studies-in-professional-and-patient-advocacy-relations?opendocument
18
19opendocument
2018.97.14.81
21
22
23
24/bestp/domrep.nsf
25DB